Susquehanna International Group
ANAC

Susquehanna International Group’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Susquehanna International Group’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-101,038
Closed -$5.4M – 10168
2016
Q1 		$5.4M Buy
101,038
+12,695
+14% +$937K ﹤0.01% 2209
2015
Q4 		$9.98M Buy
88,343
+43,053
+95% +$4.74M ﹤0.01% 1757
2015
Q3 		$5.33M Sell
45,290
-436,252
-91% -$57M ﹤0.01% 2591
2015
Q2 		$37.3M Buy
481,542
+163,911
+52% +$10.7M 0.02% 860
2015
Q1 		$18.4M Buy
317,631
+231,784
+270% +$9.84M 0.01% 1299
2014
Q4 		$2.77M Buy
85,847
+50,730
+144% +$1.52M ﹤0.01% 3865
2014
Q3 		$859K Buy
35,117
+21,740
+163% +$442K ﹤0.01% 6221
2014
Q2 		$237K Sell
13,377
-19,236
-59% -$310K ﹤0.01% 8792
2014
Q1 		$653K Buy
32,613
+18,377
+129% +$356K ﹤0.01% 6282
2013
Q4 		$239K Buy
14,236
+2,668
+23% +$36.9K ﹤0.01% 7977
2013
Q3 		$123K Buy
+11,568
New +$101K ﹤0.01% 8011

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Susquehanna International Group's ANAC Position: Q2 2016 in Review

Susquehanna International Group sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 101,038 shares — an estimated $5.4M sold.

Susquehanna International Group first reported a position in ANAC in Q3 2013 and held it in 11 quarters. The position peaked at $37.3M in Q2 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Susquehanna International Group reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Susquehanna International Group sold 101,038 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $5.4M.
  • Susquehanna International Group first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2013 and held it in 11 quarters.
  • Susquehanna International Group's ANACOR PHARMACEUTICALS INC COM position peaked at $37.3M in Q2 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Susquehanna International Group's 13F filing for Q2 2016, filed 15 Aug 2016.